Statements and Testimony - 2002

  • July 16, 2002 - FDA on its Draft Guidance Document, "Guidance for Industry: Use of Nucleic Acid Tests"
    ASM's Laboratory Practices Committee submitted comments to the Food and Drug Administration regarding its draft guidance document, "Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components for Transfusion to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV," published in the Federal Register on April 9, 2002.
  • July 11, 2002 - NCCI Version 8.3 CPT Coding Edits
    ASM provided comments to the Centers for Medicare and Medicaid Services (CMS) federal contractor, AdminaStar Federal, regarding the National Corrective Coding Initiative (NCCI) version 8.3 edits.
  • July 11, 2002 - Possession of a Select Agent
    ASM submitted comments to the Centers for Disease Control and Prevention on the July 2, Federal Register notice on proposed data collections for notification of possession of a select agent.
  • June 17, 2002 - Draft Guideline for Disinfection and Sterilization in Healthcare Facilities
    The ASM submitted comments to the Centers for Disease Control and Prevention on the Draft Guideline for Sterlization and Disinfection in Healthcare Facilities. The guideline, which was published in the April 30 Federal Register, is intended to replace the section in Guideline for Handwashing and Hospital Environmental Control, 1985, that dealt with sterilization and disinfection.



TPL_asm2013_SEARCH